Nordic Mentor Network for Entrepreneurship (NOME) will be an important piece of the puzzle if Norway is going to fulfill their ambitions set by the coming White Paper on the Healthcare Industry. If we are to make our bioindustry more competitive and take a leading European role within eHealth, we need to learn from the […]
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 302 entries.
Entries by oslocancer
Researchers at the Centre for Cancer Biomedicine, a Center of Excellence and a member of Oslo Cancer Cluster, have discovered an enzyme wreaking havoc inside cells that turns into tumors. For our body to work as normal, cells need to know which way is up. When cells lose track of their orientation, they can start […]
This week on Monday, Prostate Cancer Day, the Norwegian Cancer Society initiated their Blue-Ribbon Campaign to raise prostate cancer awareness. In line with the campaign, Oslo Cancer Cluster gives you the chance to update yourselves on prostate cancer research Thursday the 30th of November. The Blue-Ribbon campaign is initially a month’s focus on prostate […]
Investors are recognizing the huge potential of Oslo Cancer Cluster member Ultimovacs. They are currently investing an additional 125 million NOK in the cancer research company. Well known investors and Ultimovacs backers Stein Erik Hagen, Anders Wilhelmsen og Bjørn Rune Gjelsten are among financiers putting fresh money into the cancer research company, according to […]
Oslo Cancer Cluster member Photucure recently announced that the U.S. Food and Drug Administration (FDA) has accepted a Priority Review for an expansion of Cysview. The FDA has accepted a supplemental New Drug Application (NDA) for Cysview on a priority review basis. Photocure, the Oslo, Norway-based company that developed and is marketing the drug-device […]
Targovax has received very positive results regarding the survival rate of patients with pancreatic cancer. Immune-oncology aims to help the body’s own immune system fight cancer and the ambition is to address the unmet need for long-term survival for patients with advanced cancers. 13 of 13 The company specializes in immune-oncology and is a member […]
En kortere versjon av denne kronikken sto på trykk i Aftenposten 13.10.2017. Du kan lese innlegget i Aftenposten her. Vi må forhindre at digital helse blir digitalt kvakksalveri. Hva får vi hvis vi smelter sammen teknologi og biologi? Jo, digital helse. Her finner vi et kinderegg for pasienter, leger og forskere. Det inneholder unike muligheter til […]
Curida has come a long way from defending their place at the Norwegian factory to setting their sights internationally. What is Curida and their goal all about? Creating value within ones own country while steadily spreading roots globally is no easy feat, but the young Norwegian pharmaceutical company Curida is blooming. Overcoming the threat at Elverum […]
Luckily, all our events at Oslo Innovation Week and Forskningsdagene are available for a rerun. Have a look! We had great audiences during our three events on the 27th and 28th of September. If your were not among them, sitting in the brand new science centre of the Norwegian Cancer Society, do not despair. The events were all live […]
The innovation company of the year wants to encourage young talents. Six students from Ullern Upper Secondary School spent their school day at Thermo Fisher Scientific just days after the company won the prestigious award as the innovation company of the year in Norway. As part of the school collaboration between Ullern Upper Secondary School and […]
Contact Team >
Oslo Cancer Cluster Incubator will support promising oncology biotechs to commercialize successfully.
The Incubator provides a dynamic, creative, and professional growth environment for scientists and start-ups.